Abbott Laboratories(ABT)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

ABT iron condor setups ABT expected move ABT IV rank history

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ABT $95.77 —
Snapshot
$95.77
52-Week Range
$81.97 – $137.49
YTD
-22.88%
IV Rank (30D)
27.0
Straddle Price
$8.15
P/C Vol Ratio
0.99
Market Cap
$166.2B
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.44%
Beta vs SPY0.66
Cost of Equity (CAPM)7.76% (VRP-adj)
WACC8.66%
Volatility Risk Premium+12.4pp (IV − HV30)
Effective Tax Rate22.9%
Rev. Growth (YoY, DCF input)+0.2%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.00 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$7.4B
Return on Equity (TTM)12.1%
Book / Price31.6% — banking bias active (P/B is primary)
Gross Margin (TTM)56.3%
FCF Margin (TTM)16.3%
Debt / Equity0.56
Quality Score3/6 — normal (10y DCF)
Market-Implied Growth+9.8% (reverse-DCF on current price)
SMA 50$88.92 (Market Anchor value)
SMA 20 / Bollinger Mid$90.69
Bollinger Width / SMA209.6% (drives anchor stability)
Net Debt$22.8B
Market Cap$167B
Peers used for multiples: PFE, REGN, TEVA (SIC-code peers; ETF co-membership was sector-incoherent)
Model Conviction
85%
20-Day Fair Value
$93.79
α -1.7% rank 17%
40-Day Fair Value
$89.99
α -5.7% rank 17%
60-Day Fair Value
$81.19
α -14.9% rank 17%
MethodImplied PriceWeightDetail
DCF $48.18 17%
DDM (Gordon) $40.65 13%
Peer P/E $65.18 5% median 18.2× · 3 peers
Peer EV/EBITDA $51.69 5% median 10.4× · 3 peers
Peer P/B $62.74 5% median 2.1× · 3 peers
Peer P/S $57.98 5% median 2.2× · 3 peers
Market Anchor (SMA50) $88.92 33% stability 100% (BB-width)
Options Expected (B-L 30d) $82.86 17% 30 strikes · skew +0.16
As of 2026-07-03 · updated 2026-07-03 20:59:30.383000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNYS
Market Cap
$166.2B

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +0.44% 23
Feb +1.04% 23
Mar -0.22% 23
Apr -0.08% 23
May +0.47% 23
Jun +1.23% 23
Jul +2.60% 23
Aug -0.40% 22
Sep -0.03% 23
Oct +0.46% 23
Nov +1.09% 23
Dec +2.06% 23
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $90.94
SMA 50: $89.00
SMA 200: $111.64
Current: $95.76
EMA 12: $92.32
EMA 26: $91.01
MACD: 1.3075 | Signal: 0.6218
BULLISH
ADX (14): 21.42
WEAK TREND
+DI: 25.99
−DI: 15.04
Momentum Oscillators
RSI (14): 63.43
NEUTRAL
Stoch %K: 85.08
Stoch %D: 70.16
Williams %R: -1.16
Volume & Volatility
BB Upper: $95.48
BB Lower: $86.40
OVERBOUGHT
OBV: -127,141,519
Vol SMA 20: 13,803,328
Vol ROC: -84.20%
ATR: $2.55
True Range: $2.87
HV 20: 28.3%
HV 30: 27.8%
HV 60: 30.2%
Data Summary
Data Points: 500
Last Updated: 2026-07-06T18:55:10.506000
Date Range: 2024-07-05T00:00:00 – 2026-07-02T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
3 of 7 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-07-18 Pre-Market 4.47% 4.51% 1.01x Exceeded
2024-10-16 Pre-Market 3.38% 1.36% 0.40x Within
2025-01-22 Pre-Market 3.20% 1.13% 0.35x Within
2025-07-17 Pre-Market 3.57% 8.45% 2.37x Exceeded
2025-10-15 Pre-Market 3.61% 2.91% 0.81x Within
2026-01-22 Pre-Market 3.84% 10.17% 2.65x Exceeded
2026-04-16 Pre-Market 5.07% 5.81% 1.15x Exceeded
Options Activity
IV Rank (30D)
27.0
IV Rank (7D)
100
Avg IV
39.6%
Straddle (30D)
$8.15
Straddle (7D)
$2.80
P/C Volume
0.99
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.13
Correlation (SPY)
6.4%
R²
0.00
Ann. Volatility
25.1%
SPY Volatility
12.6%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 1,747,067,250 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

3,206 filers1,389,738,893 shares$142.96B value79.55% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 175,556,716 $22.00B 15.39% 10.05% 2025-12-31
2 BlackRock, Inc. Custodian 145,687,458 $14.96B 10.46% 8.34% 2026-03-31
3 STATE STREET CORP 79,575,468 $8.17B 5.71% 4.55% 2026-03-31
4 Capital Research Global Investors 49,775,362 $5.11B 3.57% 2.85% 2026-03-31
5 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 45,500,055 $4.67B 3.27% 2.60% 2026-03-31
6 MORGAN STANLEY Custodian 36,727,533 $4.60B 3.22% 2.10% 2025-12-31
7 GEODE CAPITAL MANAGEMENT, LLC Custodian 39,148,795 $4.00B 2.80% 2.24% 2026-03-31
8 Capital International Investors 37,498,227 $3.85B 2.69% 2.15% 2026-03-31
9 WELLINGTON MANAGEMENT GROUP LLP Custodian 27,070,518 $2.78B 1.94% 1.55% 2026-03-31
10 JPMORGAN CHASE & CO Custodian 26,767,099 $2.73B 1.91% 1.53% 2026-03-31
11 FRANKLIN RESOURCES INC Custodian 20,022,905 $2.06B 1.44% 1.15% 2026-03-31
12 NORTHERN TRUST CORP Custodian 19,394,974 $1.99B 1.39% 1.11% 2026-03-31
13 BANK OF AMERICA CORP /DE/ Custodian 19,279,608 $1.98B 1.38% 1.10% 2026-03-31
14 WELLS FARGO & COMPANY/MN Custodian 15,909,341 $1.63B 1.14% 0.91% 2026-03-31
15 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 15,499,870 $1.61B 1.13% 0.89% 2026-03-31
16 GOLDMAN SACHS GROUP INC Custodian 14,505,201 $1.49B 1.04% 0.83% 2026-03-31
17 DEUTSCHE BANK AG\ Custodian 14,091,704 $1.45B 1.01% 0.81% 2026-03-31
18 AMERIPRISE FINANCIAL INC Custodian 14,119,549 $1.45B 1.01% 0.81% 2026-03-31
19 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 13,587,118 $1.39B 0.98% 0.78% 2026-03-31
20 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME Custodian 13,198,740 $1.36B 0.95% 0.76% 2026-03-31
21 Bank of New York Mellon Corp Custodian 12,442,717 $1.28B 0.89% 0.71% 2026-03-31
22 Legal & General Group Plc Custodian 12,285,529 $1.26B 0.88% 0.70% 2026-03-31
23 UBS Group AG Custodian 12,152,765 $1.25B 0.87% 0.70% 2026-03-31
24 Nuveen, LLC Custodian 11,191,853 $1.15B 0.80% 0.64% 2026-03-31
25 FMR LLC Custodian 10,845,315 $1.11B 0.78% 0.62% 2026-03-31
46 filers$857.30M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $174.98M 20.41% 2026-03-31
2 CITADEL ADVISORS LLC Custodian $161.38M 18.82% 2026-03-31
3 JANE STREET GROUP, LLC Custodian $129.29M 15.08% 2026-03-31
4 UBS Group AG Custodian $61.00M 7.12% 2026-03-31
5 Cubist Systematic Strategies, LLC $42.18M 4.92% 2025-09-30
6 WOLVERINE TRADING, LLC Custodian $35.73M 4.17% 2025-09-30
7 Point72 Asset Management, L.P. $24.82M 2.89% 2026-03-31
8 BNP PARIBAS FINANCIAL MARKETS Custodian $22.37M 2.61% 2026-03-31
9 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt $21.67M 2.53% 2024-09-30
10 Eisler Capital Management Ltd. $21.07M 2.46% 2025-09-30
11 CITIGROUP INC Custodian $13.93M 1.63% 2026-03-31
12 Parallax Volatility Advisers, L.P. $13.91M 1.62% 2026-03-31
13 Walleye Trading LLC $12.89M 1.50% 2026-03-31
14 Walleye Capital LLC $12.31M 1.44% 2026-03-31
15 Squarepoint Ops LLC $11.95M 1.39% 2026-03-31
16 GOLDMAN SACHS GROUP INC Custodian $11.38M 1.33% 2026-03-31
17 LOCUST WOOD CAPITAL ADVISERS, LLC $11.16M 1.30% 2026-03-31
18 BlackRock, Inc. Custodian $10.93M 1.28% 2026-03-31
19 MILLENNIUM MANAGEMENT LLC Custodian $10.78M 1.26% 2026-03-31
20 D. E. Shaw & Co., Inc. Custodian $10.63M 1.24% 2026-03-31
21 Allianz Asset Management GmbH $8.40M 0.98% 2026-03-31
22 Qube Research & Technologies Ltd $4.91M 0.57% 2026-03-31
23 BALYASNY ASSET MANAGEMENT L.P. $4.80M 0.56% 2026-03-31
24 TUDOR INVESTMENT CORP ET AL $3.56M 0.42% 2026-03-31
25 CAPSTONE INVESTMENT ADVISORS, LLC $3.02M 0.35% 2026-03-31
46 filers$1.05B notional
# Filer Notional Value % of Total Period
1 UBS Group AG Custodian $301.96M 28.65% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $175.85M 16.69% 2026-03-31
3 CITIGROUP INC Custodian $116.95M 11.10% 2026-03-31
4 JANE STREET GROUP, LLC Custodian $87.32M 8.29% 2026-03-31
5 Eisler Capital Management Ltd. $56.43M 5.35% 2025-09-30
6 GOLDMAN SACHS GROUP INC Custodian $54.02M 5.13% 2026-03-31
7 MILLENNIUM MANAGEMENT LLC Custodian $47.08M 4.47% 2026-03-31
8 CITADEL ADVISORS LLC Custodian $34.15M 3.24% 2026-03-31
9 TUDOR INVESTMENT CORP ET AL $25.58M 2.43% 2026-03-31
10 BNP PARIBAS FINANCIAL MARKETS Custodian $18.07M 1.71% 2026-03-31
11 CAPSTONE INVESTMENT ADVISORS, LLC $16.28M 1.55% 2026-03-31
12 Qube Research & Technologies Ltd $12.27M 1.16% 2026-03-31
13 WOLVERINE TRADING, LLC Custodian $11.15M 1.06% 2025-09-30
14 Allianz Asset Management GmbH $11.01M 1.04% 2026-03-31
15 BALYASNY ASSET MANAGEMENT L.P. $9.88M 0.94% 2026-03-31
16 Squarepoint Ops LLC $7.65M 0.73% 2026-03-31
17 Point72 Asset Management, L.P. $6.48M 0.61% 2026-03-31
18 BARCLAYS PLC Custodian $6.16M 0.58% 2026-03-31
19 Walleye Capital LLC $5.76M 0.55% 2026-03-31
20 CREDIT INDUSTRIEL ET COMMERCIAL $5.13M 0.49% 2026-03-31
21 Walleye Trading LLC $4.94M 0.47% 2026-03-31
22 LOGAN CAPITAL MANAGEMENT INC $4.37M 0.41% 2026-03-31
23 CAPITAL FUND MANAGEMENT S.A. $4.33M 0.41% 2026-03-31
24 CREDIT AGRICOLE S A $4.11M 0.39% 2026-03-31
25 TWO SIGMA INVESTMENTS, LP $2.71M 0.26% 2026-03-31
Insider Activity
Latest: 2026-07-01
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-01 Patricia Paola Gonzalez Director Grant (A) +363 RSU — EDGAR
2026-07-01 Nita Ahuja Director Grant (A) +347 RSU — EDGAR
2026-07-01 Michael F Roman Director Grant (A) +416 RSU — EDGAR
2026-07-01 Kevin T Conroy Director Grant (A) +231 RSU — EDGAR
2026-07-01 Louis H. Morrone EXECUTIVE VICE PRESIDENT Tax (F) −269 $92.71 -$24.9K EDGAR
2026-07-01 John G Stratton Director Grant (A) +432 RSU — EDGAR
2026-06-29 Elizabeth C. Cushman EVP, GC AND SECRETARY Tax (F) −560 $94.12 -$52.7K EDGAR
2026-06-18 John G Stratton Director Buy (P) +2,000 $86.82 $173.6K EDGAR
2026-04-29 Mary K Moreland EXECUTIVE VICE PRESIDENT I +5,314 $94.41 $501.7K EDGAR
2026-04-28 Nita Ahuja Director Award (A) +2,286 — EDGAR
2026-04-28 Claire Babineaux-Fontenot Director Award (A) +2,286 — EDGAR
2026-04-28 Sally E. Blount Director Award (A) +2,286 — EDGAR
2026-04-28 Patricia Paola Gonzalez Director Award (A) +2,286 — EDGAR
2026-04-28 Michelle Kumbier Director Award (A) +2,286 — EDGAR
2026-04-28 Darren W McDew Director Award (A) +2,286 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
100 insiders · @ $95.76
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 DANIEL J STARKS Director 6,751,361 $646.51M -$25.67M 21 2026-04-28
2 MILES D WHITE EXECUTIVE CHAIRMAN 3,128,641 $299.60M -$244.08M 99 2021-12-08
3 MICHAEL T ROUSSEAU Pres., Cardiovas. & Neuromod. 629,294 $60.26M $0 2 2017-07-11
4 Brian J. Blaser Executive Vice President 580,807 $55.62M -$49.95M 45 2019-05-24
5 Robert B Ford CHAIRMAN AND CEO 522,664 $50.05M -$67.51M 49 2026-03-03
6 THOMAS C FREYMAN Executive Vice President 514,682 $49.29M -$6.97M 51 2016-07-29
7 Eric S Fain Senior Vice President 493,961 $47.30M $0 5 2017-09-29
8 RICHARD W ASHLEY Executive Vice President 354,517 $33.95M -$902.6K 22 2016-03-02
9 JOHN M CAPEK EXECUTIVE VICE PRESIDENT 339,443 $32.51M -$52.80M 47 2023-03-02
10 Laura J Schumacher Executive Vice President 299,115 $28.64M -$19.89M 38 2012-12-13
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-05-15
Last 30d: 0 filings  ·  Last 90d: 2 filings · $3.4M notice value · 1 unique filer

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Top 90-day filers: Robert J. Alpern (2, $3.4M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-05-15 Robert J. Alpern Retired Director 7,587 $646.8K 2026-05-15 Janney Montgomery Scott LLC — EDGAR
2026-04-27 Robert J. Alpern Retired Director 29,211 $2.70M 2026-04-27 UBS Financial Services, Inc. — EDGAR
2026-03-02 Elizabeth C. Cushman Officer 263 $30.4K 2026-03-02 UBS Financial Services, Inc. — EDGAR
2026-03-02 Eric Shroff Officer 709 $81.9K 2026-03-02 UBS Financial Services, Inc. — EDGAR
2026-03-02 Louis H. Morrone Officer 1,144 $132.2K 2026-03-02 UBS Financial Services, Inc. — EDGAR
2026-03-02 Mary K. Moreland Officer 613 $70.8K 2026-03-02 UBS Financial Services, Inc. — EDGAR
2026-03-02 John A. McCoy, Jr. Officer 585 $67.6K 2026-03-02 UBS Financial Services, Inc. — EDGAR
2026-03-02 Daniel Gesua Sive Salvadori Officer 885 $102.3K 2026-03-02 UBS Financial Services, Inc. — EDGAR
2025-11-25 Eric Shroff Officer 1,586 $203.0K 2025-11-25 UBS Financial Services, Inc. — EDGAR
2025-08-08 Boudreau Philip P Officer 5,550 $746.8K 2025-08-08 UBS Financial Services, Inc. — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
Recent SEC Filings
Latest: 2026-04-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-04-27 0001104659-26-049434 EDGAR
2026-04-17 0001104659-26-044892 EDGAR
2026-04-16 0001628280-26-025365 EDGAR
2026-03-23 0001104659-26-033079 EDGAR
2026-03-09 0001104659-26-025240 EDGAR
2026-02-26 0001104659-26-020509 EDGAR
2026-02-20 0001104659-26-018167 EDGAR
2026-01-22 0001628280-26-002982 EDGAR
2025-12-12 0001104659-25-120657 EDGAR
2025-11-21 0001104659-25-114995 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-20 0001628280-26-010185 EDGAR
2025-02-21 0001628280-25-007110 EDGAR
2024-02-16 0001628280-24-005348 EDGAR
2023-02-17 0001628280-23-004026 EDGAR
2022-02-18 0001104659-22-025141 EDGAR
2021-02-19 0001104659-21-025751 EDGAR
2020-02-21 0001104659-20-023904 EDGAR
2019-02-22 0001047469-19-000624 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-04-29 0001628280-26-028357 EDGAR
2025-10-29 0001628280-25-047131 EDGAR
2025-07-30 0001628280-25-036720 EDGAR
2025-04-30 0001628280-25-021090 EDGAR
2024-10-31 0001628280-24-044602 EDGAR
2024-07-31 0001628280-24-033740 EDGAR
2024-05-02 0001628280-24-020011 EDGAR
2023-11-01 0001628280-23-035957 EDGAR
2023-08-03 0001628280-23-027203 EDGAR
2023-05-04 0001628280-23-015699 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio26.8
P/B Ratio3.2
P/S Ratio3.7
EV/EBITDA17.8
TTM Revenue$45.1B
TTM Net Income$6.3B
TTM EPS$3.58
ROE12.1%
Dividend Yield2.52%
Debt/Equity0.65